Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Annales De Biologie Clinique|October 7, 2020
[Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?]Michael Hardy, Jonathan Douxfils, Jean-Michel Dogné, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|June 22, 2011
[Divisibility of warfarin and fluindione tablets tested in elderly patients and their family circle]Eric Pautas, Jérémie Despres, Isabelle Peyron, et al.
Anaesthesia, Critical Care & Pain Medicine|October 21, 2021
GFHT proposals on the practical use of argatroban - With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT)Virginie Siguret, Elodie Boissier, Emmanuel De Maistre, et al.
Thrombosis and Haemostasis|March 13, 2015
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxabanGeorges Jourdi, Virginie Siguret, Anne Céline Martin, et al.
Anesthesiology|May 13, 2021
Combined Platelet and Erythrocyte Salvage: Evaluation of a New Filtration-based Autotransfusion DeviceAlexandre Mansour, Benoit Decouture, Mikaël Roussel, et al.
Annales De Biologie Clinique|April 11, 2015
[Non-VKA oral anticoagulants: an update for the clinical biologists]François Mullier, Jonathan Douxfils, Anne Tamigniau, et al.
European Journal of Anaesthesiology|September 10, 2015
The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: An in-vitro studyAnne-Céline Martin, Célia Berndt, Leyla Calmette, et al.
Journal of Cardiothoracic and Vascular Anesthesia|April 11, 2024
Impact of Intraoperative Allogeneic Platelet Transfusion on Healthcare-Associated Infections in Cardiac Surgery: Insights From a Large Single-Center Cohort StudyAlexandre Mansour, Nicolas Massart, Isabelle Gouin-Thibault, et al.
Research and Practice in Thrombosis and Haemostasis|March 9, 2023
Impact of age on in vitro metabolism of clopidogrel: a potential explanation for high on-treatment platelet reactivity in the elderly?Adeline Pontis, Xavier Delavenne, Marie-Clémence Verdier, et al.
Thrombosis Research|August 31, 2015
Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrationsAnne Godier, Anne-Céline Martin, Isabelle Leblanc, et al.
Pageof 9